Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells

Stem Cells

Volumn 26, Issue 2, 2008, Pages 517-524

  Maxwell, Dustin J ^a   Bonde, Jesper ^b   Hess, David A ^c   Hohm, Sarah A ^b   Lahey, Ryan ^d   Zhou, Ping ^d   Creer, Michael H ^e   Piwnica Worms, David ^a   Nolta, Jan A ^d,f  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Feridex; Hematopoiesis; Human stem cells; Immune deficient mice; Iron oxide; Nanoparticle; Transplantation

Indexed keywords

DEXTRAN; NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ARTICLE; CD34 SELECTION; CELL CYCLE; CELL FATE; CELL LABELING; CELL POPULATION; CELL SELECTION; CONTROLLED STUDY; ENGRAFTMENT; FLOW CYTOMETRY; FLUORESCENCE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN;

ANIMALS; ANTIGENS, CD34; CELL CYCLE; CELL SURVIVAL; COLONY-FORMING UNITS ASSAY; FLUORESCENT DYES; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; IRON; METAL NANOPARTICLES; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; MICE, SCID; OXIDES; TRANSPLANTATION, HETEROLOGOUS;

MUS;

EID: 40949124303     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0016     Document Type: Article

References (40)

1. Bonde J, Hess DA, Nolta JA. Recent advances in hematopoietic stem cell biology. Curr Opin Hematol 2004;11:392-398.
2. Hacein-Bey-Abina S, von Kalle C, Schmidt M et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N. Engl J Med 2003;348:255-256.
3. Daldrup-Link H, Rudelius M, Piontek G et al. Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: In vivo monitoring with 1.5-T MR imaging equipment. Radiology 2005;234:197-205.
4. Daldrup-Link HE, Rummeny EJ, Ihssen B et al. Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: Differentiation between tumor infiltration and hypercellular bone marrow. Eur Radiol 2002;12:1557-1566.
5. Daldrup-Link HE, Rudelius M, Ooostendorp R et al. Comparison of iron oxide labeling properties of hematopoietic progenitor cells from umbilical cord blood and from peripheral blood for subsequent in vivo tracking in a xenotransplant mouse model. Acad Radiol 2005;12:502-510.
6. Kircher M, Allport J, Graves E et al. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic T-lymphocyte trafficking to tumors. Cancer Res 2003;63:6838-6846.
7. Lewin M, Carlesso N, Tung CH et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat Biotechnol 2000;18:410-414.
8. Weissleder R, Cheng HC, Bogdanova A. Magnetically labeled cells can be detected by MR imaging. J Magn Reson Imaging 1997;7:258-263.
9. Arbab A, Bashaw L, Miller B et al. Characterization of biophysical and metabolic properties of cells labeled with superparamagnetic iron oxide nanoparticles and transfection agent for cellular MR imaging. Radiology 2003;229:838-846.
10. Arbab AS. Intracytoplasmic tagging of cells with ferumoxides and transfection agent for cellular magnetic resonance imaging after cell transplantation: Methods and techniques. Transplantation 2003;76:1123-1130.
11. Arbab AS. Efficient magnetic cell labeling with protamine sulfate complexed to ferumoxides for cellular MRI. Blood 2004;104:1217-1223.
12. Arbab AS. Comparison of transfection agents in forming complexes with ferumoxides, cell labeling efficiency, and cellular viability. Mol Imaging 2004;3:24-32.
13. Frank JA, Miller BR, Arbab AS et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology 2003;228:480-487.
14. Hogemann D, Josephson L, Weissleder, R., Basilion JP. Improvement of MRI probes to allow efficient detection of gene expression. Bioconjug Chem 2000;11:941-946.
15. Josephson L, Tung CH, Moore A et al. High-efficiency intracellular magnetic labeling with novel superparamagnetic-Tat peptide conjugates. Bioconjug Chem 1999;10:186-191.
16. Koch A, Reynolds F, Kirscher M et al. Uptake and metabolism of a dual fluorochrome Tat-nanoparticle in HeLa cells. Bioconjug Chem 2003;14:1115-1121.
17. Zhao M, Kircher M, Josephson L et al. Differential conjugation of Tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. Bioconjug Chem 2002;13:840-844.
18. Hess DA, Meyerrose TE, Wirthlin L et al. Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity. Blood 2004;104:1648-1655.
19. Kida T, Yokota M, Masuyama A et al. A facile synthesis of polyglycidyl ethers from polyols and epichlorohydrin. Synthesis 1993;487-489.
20. Stookey LL. Ferrozine, a new spectrophotometric reagent for iron. Anal Chem 1970;42:779-781.
21. Dao MA, Nolta JA. Cytokine and integrin stimulation synergize to promote higher levels of GATA-2, c-myb, and CD34 protein in primary human hematopoietic progenitors from bone marrow. Blood 2007;109:2373-2379.
22. Hanenberg H, Hashino K, Konishi H et al. Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells. Hum Gene Ther 1997;8:2193-2206.
23. Pollok KE, Hanenberg H, Noblitt TW et al. High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments. J Virol 1998;72:4882-4892.
24. Dao MA, Hashino K, Kato I et al. Adhesion to fibronectin maintains regenerative capacity during ex vivo culture and transduction of human hematopoietic stem and progenitor cells. Blood 1998;92:4612-4621.
25. Christianson SW, Greiner DL, Hesselton RA et al. Enhanced human CD4+ T cell engraftment in beta2-microglobulin-deficient NOD-scid mice. J Immunol 1997;158:3578-3586.
26. Kollet O, Peled A, Byk T et al. beta2 microglobulin-deficient (B2m(null)) NOD/SCID mice are excellent recipients for studying human stem cell function. Blood 2000;95:3102-3105.
27. Dao MA, Taylor N, Nolta JA. Reduction in levels of the cyclin-dependent kinase inhibitor p27(kip-1) coupled with transforming growth factor beta neutralization induces cell-cycle entry and increases retroviral transduction of primitive human hematopoietic cells. Proc Natl Acad Sci U S A 1998;95:13006-13011.
28. Dao MA, Hwa J, Nolta JA. Molecular mechanism of transforming growth factor beta-mediated cell-cycle modulation in primary human CD34(+) progenitors. Blood 2002;99:499-506.
29. Metz S, Bonaterra G, Rudelius M et al. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 2004;14:1851-1858.
30. Raynal I, Prigent P, Peyramaure S et al. Macrophage endocytosis of superparamagnetic iron oxide nanoparticles: Mechanisms and comparison of ferumoxides and ferumoxtran-10. Invest Radiol 2004;39:56-63.
31. Rogers WJ, Basu P. Factors regulating macrophage endocytosis of nanoparticles: Implications for targeted magnetic resonance plaque imaging. Atherosclerosis 2005;178:67-73.
32. Sipe JC, Filippi M, Martino G et al. Method for intracellular magnetic labeling of human mononuclear cells using approved iron contrast agents. Magn Reson Imaging 1999;17:1521-1523.
33. Miller DG, Adam MA, Miller AD. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection [published erratum appears in Mol Cell Biol 1992;12:433]. Mol Cell Biol 1990;10:4239-4242.
34. Sutton RE, Reitsma MJ, Uchida N et al. Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent. J Virol 1999;73:3649-3660.
35. Kohn DB, Sadelain M, Dunbar C et al. American Society of Gene Therapy (ASGT) ad hoc subcommittee on retroviral-mediated gene transfer to hematopoietic stem cells. Mol Ther 2003;8:180-187.
36. Oostendorp R, Ghaffari S, Eaves C. Kinetics of in vivo homing and recruitment into cycle of hematopoietic cells are organ-specific but CD44-independent. Bone Marrow Transplant 2000;26:559-566.
37. Arbab AS, Wilson LB, Ashari P et al. A model of lysosomal metabolism of dextran coated superparamagnetic iron oxide (SPIO) nanoparticles: Implications for cellular magnetic resonance imaging. NMR Biomed 2005;18:383-389.
38. Daldrup-Link HEea. Targeting of hematopoietic progenitor cells with MR contrast agents. Radiology 2003;228:760-767.
39. Cashman J, Lapidot T, Wang J et al. Kinetic evidence of the regeneration of multilineage hematopoiesis from primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood 1997;89:4307-4316.
40. Anderson SA, Glod J, Arbab AS et al. Noninvasive MR imaging of magnetically labeled stem cells to directly identify neovasculature in a glioma model. Blood 2005;105:420-425.